Ubs Asset Management Americas Inc Olink Holding Ab (Publ) Transaction History

Ubs Asset Management Americas Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$19.34 - $24.11 $234,014 - $291,731	-12,100 Reduced 4.52%	255,400 $5.75 Million
Q3 2022 Nov 14, 2022	SELL	$12.14 - $18.42 $876,508 - $1.33 Million	-72,200 Reduced 21.25%	267,500 $3.25 Million
Q1 2022 May 16, 2022	BUY	$11.33 - $19.3 $782,903 - $1.33 Million	69,100 Added 25.54%	339,700 $6 Million
Q4 2021 Feb 14, 2022	SELL	$18.0 - $34.82 $2.77 Million - $5.36 Million	-153,904 Reduced 36.26%	270,600 $4.92 Million
Q3 2021 Nov 15, 2021	BUY	$23.42 - $37.93 $1.95 Million - $3.16 Million	83,204 Added 24.38%	424,504 $10.3 Million
Q2 2021 Aug 16, 2021	BUY	$26.65 - $39.47 $1.14 Million - $1.69 Million	42,800 Added 14.34%	341,300 $11.7 Million
Q1 2021 May 14, 2021	BUY	$31.9 - $36.0 $9.52 Million - $10.7 Million	298,500 New	298,500 $10.7 Million

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.